324 Dose-seeking phase I trials (DSPT) of approved molecularly targeted therapies (MTT): Exhaustiveness and readability of published clinical reports
Authors:
- S. CousinSCS. Cousin
- A. HollebecqueAHA. Hollebecque
- N. IsambertNIN. Isambert
- A. ItalianoAIA. Italiano
- N. KoteckiNKN. Kotecki
- S. Postel-VinaySPS. Postel-Vinay
- J. GobboJGJ. Gobbo
- M. ToulmondeMTM. Toulmonde
- N. PenelNPN. Penel
- 1 September 2015
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 51, S62-S63